The identified variants are therefore expected to be a mix of variants, which have been previously associated with hypo or hyperthyroidism (e.g., TPO, FOXE1, and ATXN2) and variants that lead to a TSH level, which is slightly above or below the population-based reference ranges. Here, FOXE1 is linked to hyperthyroidism.